BCL2 and acute myeloid leukemia: Venetoclax induces apoptosis by inhibiting BCL-2 and indirectly enhances the sensitivity of AML cells to ferroptosis. When combined with ferroptosis inducers, it synergistically promotes lipid peroxide accumulation, overcoming the antioxidant defense threshold of resistant cells